Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 14 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 17, 2023 22:04 UTC |
Greenstein Leonard M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 4,462 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001519692-23-000006 · wf-form4_167909066577368.xml · nonDerivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:02 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
Exercise / conversionRestricted Stock Units · Derivative | 11,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001827672-23-000018 · wf-form4_167909053944482.xml · derivative · entry 4 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,898 Underlying: Common Stock · 11,299 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F7 · derivative.exercise_date: RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service. F7 · derivative.expiration_date: RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:02 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
Exercise / conversionCommon Stock | 11,299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001827672-23-000018 · wf-form4_167909053944482.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). F4 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:02 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,000 | $13.79 | $110,320.00 |
DisclosureSEC source: 0001827672-23-000018 · wf-form4_167909053944482.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,080,536 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.52 to $14.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 22:13 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 717 | $15.01 | $10,762.17 |
DisclosureSEC source: 0001827672-23-000016 · wf-form4_167848639670548.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,088,536 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:29 UTC |
Wahl BryanGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 28,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018004 · doc4.xml · derivative · entry 2 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,993 Underlying: Common Stock · 28,993 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:29 UTC |
Wahl BryanGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 42,802 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018004 · doc4.xml · derivative · entry 1 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,802 Underlying: Common Stock · 42,802 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:31 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 28,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018005 · doc4.xml · derivative · entry 2 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,993 Underlying: Common Stock · 28,993 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:31 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
GrantStock Option (right to buy) · Derivative | 42,802 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018005 · doc4.xml · derivative · entry 1 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,802 Underlying: Common Stock · 42,802 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:28 UTC |
Trevejo Jose M.Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 30,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018003 · doc4.xml · derivative · entry 2 Trevejo Jose M. · CIK 0001661539 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,792 Underlying: Common Stock · 30,792 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:28 UTC |
Trevejo Jose M.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 45,459 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018003 · doc4.xml · derivative · entry 1 Trevejo Jose M. · CIK 0001661539 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,459 Underlying: Common Stock · 45,459 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:26 UTC |
Neervannan SeshadriChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 32,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018001 · doc4.xml · derivative · entry 2 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,592 Underlying: Common Stock · 32,592 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:26 UTC |
Neervannan SeshadriChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 48,116 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018001 · doc4.xml · derivative · entry 1 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,116 Underlying: Common Stock · 48,116 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:25 UTC |
Mottiwala AzizChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 32,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017999 · doc4.xml · derivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,592 Underlying: Common Stock · 32,592 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:25 UTC |
Mottiwala AzizChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 48,116 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017999 · doc4.xml · derivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,116 Underlying: Common Stock · 48,116 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:24 UTC |
Greenstein Leonard M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 27,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017998 · doc4.xml · derivative · entry 2 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,160 Underlying: Common Stock · 27,160 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:24 UTC |
Greenstein Leonard M.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 40,097 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017998 · doc4.xml · derivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,097 Underlying: Common Stock · 40,097 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:23 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
GrantRestricted Stock Units · Derivative | 67,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017996 · doc4.xml · derivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,900 Underlying: Common Stock · 67,900 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 00:23 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
GrantStock Option (right to buy) · Derivative | 100,242 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017996 · doc4.xml · derivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,242 Underlying: Common Stock · 100,242 shares Expires 2033-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:13 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 4,853 | $15.02 | $72,892.06 |
DisclosureSEC source: 0001827672-23-000016 · wf-form4_167848639670548.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,089,253 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:58 UTC |
Greenstein Leonard M.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $15.12 | $75,600.00 |
DisclosureSEC source: 0001519692-23-000004 · wf-form4_167667111042182.xml · nonDerivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,289 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.01 to $15.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:54 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,000 | $15.28 | $122,240.00 |
DisclosureSEC source: 0001827672-23-000014 · wf-form4_167667087235492.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,094,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.03 to $15.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 21:54 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 9,000 | $15.14 | $136,260.00 |
DisclosureSEC source: 0001827672-23-000012 · wf-form4_167606603017023.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,102,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.03 to $15.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:49 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 4,856 | $15.45 | $75,025.20 |
DisclosureSEC source: 0001827672-23-000010 · wf-form4_167468692702601.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,111,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 23:41 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 240 | $15.00 | $3,600.00 |
DisclosureSEC source: 0001827672-23-000006 · wf-form4_167425809399971.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,116,373 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 23:44 UTC |
Greenstein Leonard M.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $14.56 | $72,800.00 |
DisclosureSEC source: 0001519692-23-000002 · wf-form4_167425823782385.xml · nonDerivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,289 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.35 to $14.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 23:41 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,000 | $14.56 | $116,480.00 |
DisclosureSEC source: 0001827672-23-000006 · wf-form4_167425809399971.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,116,613 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.40 to $14.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 23:47 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 3,904 | $15.11 | $58,989.44 |
DisclosureSEC source: 0001827672-23-000004 · wf-form4_167365360777704.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,124,613 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 01:26 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 905 | $15.17 | $13,728.85 |
DisclosureSEC source: 0001827672-23-000002 · wf-form4_167348676340762.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,128,517 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 01:26 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 729 | $15.15 | $11,044.35 |
DisclosureSEC source: 0001827672-23-000002 · wf-form4_167348676340762.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,129,422 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.02 to $15.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| January 06, 2023 Filed Jan 24, 2023 23:13 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 411 | $15.00 | $6,165.00 |
DisclosureSEC source: 0001827672-23-000008 · wf-form4_167460198945770.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,129,740 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: This is an inadvertent late filing due to an administrative error. As a result of this administrative error, the shares sold on January 6, 2023 were erroneously included in the Table I, Column 5 totals of the Form 4s filed by the Reporting Person on January 11, 2023, January 13, 2023 and January 20, 2023. F4 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 23:02 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,000 | $14.57 | $116,560.00 |
DisclosureSEC source: 0001827672-22-000020 · wf-form4_167175011949009.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,130,151 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.37 to $14.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 23:35 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 535 | $15.01 | $8,030.35 |
DisclosureSEC source: 0001827672-22-000018 · wf-form4_167157931321935.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,138,151 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:55 UTC |
Greenstein Leonard M.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $14.64 | $73,200.00 |
DisclosureSEC source: 0001519692-22-000012 · wf-form4_167122772509088.xml · nonDerivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,289 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.50 to $14.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:51 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 6,420 | $15.08 | $96,813.60 |
DisclosureSEC source: 0001827672-22-000016 · wf-form4_167122749083590.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,138,686 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:59 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031476 · wf-form4_167036753237121.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F2 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:52 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
SaleCommon Stock | 1,154 | $16.90 | $19,502.60 |
DisclosureSEC source: 0001839516-22-000006 · wf-form4_167036712028292.xml · nonDerivative · entry 1 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,723 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:49 UTC |
Wahl BryanGeneral Counsel
|
SaleCommon Stock | 1,154 | $16.90 | $19,502.60 |
DisclosureSEC source: 0001841401-22-000006 · wf-form4_167036696162484.xml · nonDerivative · entry 1 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,723 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 01:09 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
SaleCommon Stock | 1,165 | $16.75 | $19,513.75 |
DisclosureSEC source: 0001839516-22-000004 · wf-form4_166994335109527.xml · nonDerivative · entry 3 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,877 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 00:58 UTC |
Wahl BryanGeneral Counsel
|
SaleCommon Stock | 1,164 | $16.75 | $19,497.00 |
DisclosureSEC source: 0001841401-22-000004 · wf-form4_166994271203193.xml · nonDerivative · entry 3 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,877 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 01:09 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
SaleCommon Stock | 1,182 | $16.50 | $19,503.00 |
DisclosureSEC source: 0001839516-22-000004 · wf-form4_166994335109527.xml · nonDerivative · entry 2 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,042 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 00:58 UTC |
Wahl BryanGeneral Counsel
|
SaleCommon Stock | 1,183 | $16.50 | $19,519.50 |
DisclosureSEC source: 0001841401-22-000004 · wf-form4_166994271203193.xml · nonDerivative · entry 2 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,041 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| November 29, 2022 Filed Dec 2, 2022 01:09 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001839516-22-000004 · wf-form4_166994335109527.xml · derivative · entry 4 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,920 Underlying: Common Stock · 10,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. F4 · derivative.exercise_date: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. Read SEC document |
| November 29, 2022 Filed Dec 2, 2022 01:09 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
Exercise / conversionCommon Stock | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001839516-22-000004 · wf-form4_166994335109527.xml · nonDerivative · entry 1 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Reporting Person received restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. This reported transaction represents the settlement of RSUs vested as of November 29, 2022. F2 · balance_after: Includes 862 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and includes 1,111 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022. Read SEC document |
| November 29, 2022 Filed Dec 2, 2022 00:58 UTC |
Wahl BryanGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001841401-22-000004 · wf-form4_166994271203193.xml · derivative · entry 4 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,920 Underlying: Common Stock · 10,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. F4 · derivative.exercise_date: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. Read SEC document |
| November 29, 2022 Filed Dec 2, 2022 00:58 UTC |
Wahl BryanGeneral Counsel
|
Exercise / conversionCommon Stock | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001841401-22-000004 · wf-form4_166994271203193.xml · nonDerivative · entry 1 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Reporting Person received restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. This reported transaction represents the settlement of RSUs vested as of November 29, 2022. F2 · balance_after: Includes 862 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and includes 1,111 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:12 UTC |
Greenstein Leonard M.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $16.54 | $82,700.00 |
DisclosureSEC source: 0001519692-22-000010 · wf-form4_166880594253223.xml · nonDerivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,289 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.22 to $16.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:09 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 745 | $17.31 | $12,895.95 |
DisclosureSEC source: 0001827672-22-000014 · wf-form4_166880576794208.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,145,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.24 to $17.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:09 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 7,255 | $16.81 | $121,956.55 |
DisclosureSEC source: 0001827672-22-000014 · wf-form4_166880576794208.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,145,851 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.24 to $17.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:30 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 6,857 | $17.72 | $121,506.04 |
DisclosureSEC source: 0001788542-22-000006 · wf-form4_166872420553318.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,729 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022. F2 · shares: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.44 to $18.18. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.